These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 29857274)

  • 21. Coaxial PCL/PVA electrospun nanofibers: osseointegration enhancer and controlled drug release device.
    Song W; Yu X; Markel DC; Shi T; Ren W
    Biofabrication; 2013 Sep; 5(3):035006. PubMed ID: 23799653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In Situ Hydroxyapatite Synthesis Enhances Biocompatibility of PVA/HA Hydrogels.
    Chocholata P; Kulda V; Dvorakova J; Supova M; Zaloudkova M; Babuska V
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancement of in vitro activity of tuberculosis drugs by addition of thioridazine is not reflected by improved in vivo therapeutic efficacy.
    de Knegt GJ; ten Kate MT; van Soolingen D; Aarnoutse R; Boeree MJ; Bakker-Woudenberg IA; de Steenwinkel JE
    Tuberculosis (Edinb); 2014 Dec; 94(6):701-7. PubMed ID: 25621361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spray-dried particles as pulmonary delivery system of anti-tubercular drugs: design, optimization, in vitro and in vivo evaluation.
    Garg T; Goyal AK; Rath G; Murthy RS
    Pharm Dev Technol; 2016 Dec; 21(8):951-960. PubMed ID: 26334961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-Mycobacterium tuberculosis activity of naphthoimidazoles combined with isoniazid and rifampicin.
    Corrêa Barros LP; Del Rio KP; Carvalho TDSC; Pinto MDCFR; de Moura KCG; Halicki PCB; Ramos DF; da Silva PEA
    Tuberculosis (Edinb); 2018 Jul; 111():198-201. PubMed ID: 30029908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-tuberculosis drug combination for controlled oral delivery using 3D printed compartmental dosage forms: From drug product design to in vivo testing.
    Genina N; Boetker JP; Colombo S; Harmankaya N; Rantanen J; Bohr A
    J Control Release; 2017 Dec; 268():40-48. PubMed ID: 28993169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concomitant increases in spectrum and level of drug resistance in Mycobacterium tuberculosis isolates.
    Sun Z; Zhang J; Song H; Zhang X; Li Y; Tian M; Liu Y; Zhao Y; Li C
    Int J Tuberc Lung Dis; 2010 Nov; 14(11):1436-41, i. PubMed ID: 20937184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of spinal tuberculosis in rabbits using bovine serum albumin nanoparticles loaded with isoniazid and rifampicin.
    Ma R; Zhang J; Chen Z; Ma H; Liu X; Liang S; Wu P; Ge Z
    Neurol Res; 2022 Mar; 44(3):268-274. PubMed ID: 34581255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Attributable factors to the emergence of multidrug-resistant Mycobacterium tuberculosis based on the observation of consecutive drug resistance test results].
    Fujino T; Hasegawa N; Satou R; Komatsu H; Kawada K
    Kekkaku; 1998 Jul; 73(7):471-6. PubMed ID: 9739579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bactericidal action of pulsed exposure to rifampicin, ethambutol, isoniazid & pyrazinamide on Mycobacterium tuberculosis in vitro.
    Paramasivan CN; Herbert D; Prabhakar R
    Indian J Med Res; 1993 Jul; 97():145-50. PubMed ID: 8406638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determination of anti-tuberculosis drug concentration and distribution from sustained release microspheres in the vertebrae of a spinal tuberculosis rabbit model.
    Liu P; Jiang H; Li S; Lin Z; Jiang J
    J Orthop Res; 2017 Jan; 35(1):200-208. PubMed ID: 26996958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tuberculosis Drug Development: History and Evolution of the Mechanism-Based Paradigm.
    Chakraborty S; Rhee KY
    Cold Spring Harb Perspect Med; 2015 Apr; 5(8):a021147. PubMed ID: 25877396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 3D scaffold with effective multidrug sequential release against bacteria biofilm.
    García-Alvarez R; Izquierdo-Barba I; Vallet-Regí M
    Acta Biomater; 2017 Feb; 49():113-126. PubMed ID: 27845276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electrospun polyvinyl alcohol-collagen-hydroxyapatite nanofibers: a biomimetic extracellular matrix for osteoblastic cells.
    Song W; Markel DC; Wang S; Shi T; Mao G; Ren W
    Nanotechnology; 2012 Mar; 23(11):115101. PubMed ID: 22370251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lower cytotoxicity, high stability, and long-term antibacterial activity of a poly(methacrylic acid)/isoniazid/rifampin nanogel against multidrug-resistant intestinal Mycobacterium tuberculosis.
    Chen T; Li Q; Guo L; Yu L; Li Z; Guo H; Li H; Zhao M; Chen L; Chen X; Zhong Q; Zhou L; Wu T
    Mater Sci Eng C Mater Biol Appl; 2016 Jan; 58():659-65. PubMed ID: 26478357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of dual delivery antituberculotic system containing rifapentine microspheres and adipose stem cells seeded in hydroxyapatite/tricalcium phosphate.
    Liang Q; Song X; She S; Wang Z; Wang C; Jiang D
    Drug Des Devel Ther; 2019; 13():373-384. PubMed ID: 30705585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isoniazid-loaded chitosan/carbon nanotubes microspheres promote secondary wound healing of bone tuberculosis.
    Chen G; Wu Y; Yu D; Li R; Luo W; Ma G; Zhang C
    J Biomater Appl; 2019 Feb; 33(7):989-996. PubMed ID: 30509120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Osteogenic effect of controlled released rhBMP-2 in 3D printed porous hydroxyapatite scaffold.
    Wang H; Wu G; Zhang J; Zhou K; Yin B; Su X; Qiu G; Yang G; Zhang X; Zhou G; Wu Z
    Colloids Surf B Biointerfaces; 2016 May; 141():491-498. PubMed ID: 26896655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Reduced mycobacterial resistance to antituberculous drugs in the experiment and clinic: immediate and long-term results].
    Belianin II; Shmelev EI
    Probl Tuberk Bolezn Legk; 2007; (2):31-8. PubMed ID: 17419333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Experimental evidence for Mycobacterium tuberculosis persistence in M. tuberculosis-infected H37RV mice in the treatment with 3 first-line drugs (rifampicin, isoniazid, pyrazinamide)].
    Smirnova TG; Chernousova LN; Andreevskaia SN; Nikolaeva GM
    Probl Tuberk Bolezn Legk; 2004; (3):32-7. PubMed ID: 15338898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.